scispace - formally typeset
Open Access

EULAR points to consider in the development of classifi cation and diagnostic criteria in systemic vasculitis

Reads0
Chats0
TLDR
Limitations in current classification criteria and definitions for vasculitis have been identified and suggestions provided for improvement and it is proposed that, in combination with the updated evidence, these should form the basis of future attempts to develop and validate revised criteria and definition of vasulitis.
Abstract
Objectives The systemic vasculitides are multiorgan diseases where early diagnosis and treatment can signifi cantly improve outcomes. Robust nomenclature reduces diagnostic delay. However, key aspects of current nomenclature are widely perceived to be out of date, these include disease defi nitions, classifi cation and diagnostic criteria. Therefore, the aim of the present work was to identify defi ciencies and provide contemporary points to consider for the development of future defi nitions and criteria in systemic vasculitis. Methods The expert panel identifi ed areas of concern within existing defi nitions/criteria. Consequently, a systematic literature review was undertaken looking to address these defi ciencies and produce ‘points to consider’ in accordance with standardised European League Against Rheumatism (EULAR) operating procedures. In the absence of evidence, expert consensus was used. Results There was unanimous consensus for re-evaluating existing defi nitions and developing new criteria. A total of 17 points to consider were proposed, covering 6 main areas: biopsy, laboratory testing, diagnostic radiology, nosology, defi nitions and research agenda. Suggestions to improve and expand current defi nitions were described including the incorporation of anti-neutrophil cytoplasm antibody and aetiological factors, where known. The importance of biopsy in diagnosis and exclusion of mimics was highlighted, while equally emphasising its problems. Thus, the role of alternative diagnostic tools such as MRI, ultrasound and surrogate markers were also discussed. Finally, structures to develop future criteria were considered. Conclusions Limitations in current classifi cation criteria and defi nitions for vasculitis have been identifi ed and suggestions provided for improvement. Additionally it is proposed that, in combination with the updated evidence, these should form the basis of future attempts to develop and validate revised criteria and defi nitions of vasculitis.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK

TL;DR: There was no major difference in AAV incidence between Japan and the U.K., but this prospective study found MPA and MPO-ANCA to be more common in Japan and granulomatosis with polyangiitis and PR3-AN CA to beMore common in theU.K, in line with earlier reports.
Journal ArticleDOI

ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

TL;DR: Accumulating evidence suggests that ANCA specificity could be better than clinical diagnosis for defining homogeneous groups of patients, as PR3-ANCA and MPO-AnCA are associated with different genetic backgrounds and epidemiology.
Journal ArticleDOI

Diagnosis and classification of polyarteritis nodosa.

TL;DR: A recent consensus algorithm for the classification of PAN has attempted to overcome some of the caveats of the 1990 American College of Rheumatology classification criteria which have proven to be unsatisfactory, and has also confirmed the low prevalence of PAN compared to other systemic necrotizing vasculitides.
References
More filters
Journal ArticleDOI

Wegener granulomatosis : an analysis of 158 patients

TL;DR: The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids, and has led to increasing concerns about toxicity resulting from prolonged cycloph phosphamide therapy and has encouraged investigation of other therapeutic regimens.
Journal ArticleDOI

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in wegener's granulomatosis

TL;DR: Immunoglobulin G (IgG) autoantibodies against extranuclear components of polymorphonuclear granulocytes were detected in 25 of 27 serum samples from patients with active Wegener's granulomatosis and in only 4 of 32 samples from Patients without signs of disease activity.
Related Papers (5)